Clinical Trials
29 trialsNasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
M.D. Anderson Cancer Center
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
NUMANTIA-2
Nelum Corp
Topical Curcumin for HPV Related Cervical Disease
Emory University
EViDENCE-BT
University of Zurich
Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
Second Affiliated Hospital of Nanchang University
Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel
University of Basrah
FMT-CACH
Changzhou No.2 People's Hospital
ART-Hypo
Centre hospitalier de l'Université de Montréal (CHUM)
ICONIC
University of Florida
Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer
George Washington University
Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer
Sun Yat-sen University
LUMInova
TNC Nutrición Terapéutica S.L.
CHILURSO
University Hospital, Montpellier
REBIRTH-013
RenJi Hospital
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
University of Chicago
125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors
Jinan Military General Hospital
Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System
Second Affiliated Hospital, School of Medicine, Zhejiang University
HYPERBOLIC
Università Vita-Salute San Raffaele
Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101
MetaFines
DECIDING
RenJi Hospital
SKB264-II-NEN
Second Affiliated Hospital, School of Medicine, Zhejiang University
Time Restricted Eating in Haematological Malignancies
British Columbia Cancer Agency
YOUNG-NEOS
Peking University People's Hospital
Immune Modulation With PRaG-1 Treatment
Second Affiliated Hospital of Soochow University
Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer
Sun Yat-sen University
Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy
Qinghai Red Cross Hospital
Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study
Tianjin Medical University Cancer Institute and Hospital
Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
Chinese University of Hong Kong